[PDF][PDF] 新型冠状病毒疫苗对奥密克戎变异株免疫保护效果研究进展

曹志强, 卢莉, 张卫, 李娟, 温小菁, 吴疆 - 中国公共卫生, 2022 - zgggws.com
新型冠状病毒(新冠病毒) 奥密克戎变异株自2021 年11 月被发现后, 快速地在世界各地广泛传播,
目前已成为全球新冠病毒传播的主要流行毒株. 在奥密克戎变异株大流行的背景下 …

Immunological and preventive effects of COVID-19 vaccine against Omicron variant–a review of research progress

Z CAO, L LU, W ZHANG - 中国公共卫生, 2022 - zgggws.com
Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant in November 2021, the coronavirus diseases 2019 (COVID-19) epidemics …

Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant …

H Xu, H Li, H You, P Zhang, N Li, N Jiang… - Emerging microbes & …, 2023 - Taylor & Francis
It is critical to determine the real-world performance of vaccines against coronavirus disease
2019 (COVID-19) so that appropriate treatments and policies can be implemented. There …

Have Previous COVID-19 Vaccinations Shaped the Potential Enhancing Infection of Variant Strains?

H Xiong, X Meng, Y Song, J Zhong, S Liu, X Zhu, X Ye… - Vaccines, 2024 - mdpi.com
Objective: This study aimed to investigate the infection status of Omicron in the population
and the association between COVID-19 vaccination and infection with Omicron. Methods …

Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA. 2 outbreak

W Ye, K Li, Z Zhao, S Wu, H Qu, Y Guo… - Frontiers in Public …, 2023 - frontiersin.org
Objective More than 90% of the Chinese population have completed 2 doses of inactivated
COVID-19 vaccines in Mainland China. However, after China government abandoned strict …

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China

J Guo, L Zha, K Zeng, M Shao, D Chen… - Chinese Medical …, 2023 - mednexus.org
To the Editor: The latest variant of concern, Omicron, has become the dominant global
variant immediately after it was first reported in November 2021.[1] It contains> 30 mutations …

[HTML][HTML] Severity and Vaccine Effectiveness in Patients With the Omicron Variant of COVID-19 in Suzhou: A Retrospective Single-Center Study

Y Cao, J Zhang, Y Zhao, F Hui, Z Hu, X Shen - Cureus, 2023 - ncbi.nlm.nih.gov
Background The Omicron variant of the coronavirus disease 2019 (COVID-19) virus has
spread rapidly worldwide, even in areas with high vaccination rates. Consequently, it has …

Clinical Characteristics and Booster Vaccine Effectiveness of the Omicron Variant

Y Shan, L Sun, Y Guo, Y Huang, Z Tang, Z Wu, Y Li… - 2024 - papers.ssrn.com
Background: Although many people received the COVID-19 vaccine, shortly after the
Chinese government announced that the three-year COVID-19 restrictions were being …

Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study

J Wang, H Dong, J Zhao, T Li, M Wang… - Frontiers in …, 2023 - frontiersin.org
Introduction The protective effect of SARS-CoV-2 vaccines has become a global focus due
to Omicron variant pandemic. The effects of various SARS-CoV-2 vaccines are diverse …

Characteristics of Omicron variant-induced SARS-CoV-2 reinfections in Chengdu, China

Y DAI, Y WANG, X DU - 中国公共卫生, 2023 - zgggws.com
Objective To explore the characteristics of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) reinfections caused by Omicron variant for providing a reference to the …